NxStage Medical Stock Hits New 52-Week Low (NXTM)

NEW YORK ( TheStreet) -- NxStage Medical Incorporated (Nasdaq: NXTM) hit a new 52-week low Thursday as it is currently trading at $16.24, below its previous 52-week low of $16.29 with 93,900 shares traded as of 10:20 a.m. ET. Average volume has been 437,400 shares over the past 30 days.

NxStage Medical has a market cap of $993.1 million and is part of the health care sector and health services industry. Shares are down 5.8% year to date as of the close of trading on Wednesday.

NxStage Medical, Inc., a medical device company, develops, manufactures, and markets products for the treatment of kidney failure, fluid overload, and related blood treatments and procedures.

TheStreet Ratings rates NxStage Medical as a sell. Among the areas we feel are negative, one of the most important has been a generally disappointing historical performance in the stock itself. You can view the full NxStage Medical Ratings Report.

See all 52-week low stocks or get investment ideas from our investment research center.
null